This is a StreetInsider.com Premium Only Page

Harmony Biosciences (HRMY) –

Apr 16, 2024 08:05 AM HARMONY BIOSCIENCES TO REPORT FIRST QUARTER 2024 FINANCIAL RESULTS ON APRIL 30, 2024

Apr 11, 2024 09:44 AM Form ARS Harmony Biosciences Hold For: Dec 31

Apr 11, 2024 08:37 AM Harmony Biosciences (HRMY) Enters into a License Agreement with Bioprojet

Apr 11, 2024 08:30 AM Form 8-K Harmony Biosciences Hold For: Apr 06

Apr 11, 2024 08:19 AM Form DEFA14A Harmony Biosciences Hold

Apr 11, 2024 08:17 AM Form DEF 14A Harmony Biosciences Hold For: May 29

Apr 11, 2024 08:05 AM HARMONY BIOSCIENCES ANNOUNCES EXCLUSIVE AGREEMENT TO DEVELOP AND COMMERCIALIZE TPM-1116, A HIGHLY POTENT AND SELECTIVE ORAL OREXIN-2 RECEPTOR AGONIST

Apr 3, 2024 08:05 AM Harmony Biosciences (HRMY) Commences Phase 3 TEMPO Study

Apr 3, 2024 08:05 AM HARMONY BIOSCIENCES INITIATES GLOBAL PHASE 3 REGISTRATIONAL TRIAL (TEMPO STUDY) OF PITOLISANT IN PATIENTS WITH PRADER-WILLI SYNDROME

Apr 2, 2024 04:31 PM Form 4 Harmony Biosciences Hold For: Mar 29 Filed by: Kapadia Sandip

Mar 26, 2024 08:05 AM HARMONY BIOSCIENCES TO PARTICIPATE IN 23RD ANNUAL NEEDHAM VIRTUAL HEALTHCARE CONFERENCE

Mar 18, 2024 07:24 PM Form 4 Harmony Biosciences Hold For: Mar 15 Filed by: Dierks Jeffrey

Mar 15, 2024 04:27 PM Form 144 Harmony Biosciences Hold Filed by: Dierks Jeffrey

Mar 11, 2024 05:18 PM Form 4 Harmony Biosciences Hold For: Mar 08 Filed by: Dierks Jeffrey

Mar 8, 2024 04:22 PM Form 144 Harmony Biosciences Hold Filed by: Dierks Jeffrey

Feb 28, 2024 05:27 PM Form 10-K/A Harmony Biosciences Hold For: Dec 31

Feb 28, 2024 08:05 AM HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

Feb 27, 2024 06:38 AM Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $40 at Mizuho Securities

Feb 23, 2024 07:33 AM Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $50 at Needham & Company

Feb 22, 2024 04:15 PM Form S-8 Harmony Biosciences Hold

Feb 22, 2024 12:00 PM Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $34 at Raymond James

Feb 22, 2024 08:01 AM Form 10-K Harmony Biosciences Hold For: Dec 31

Feb 22, 2024 07:46 AM Form 8-K Harmony Biosciences Hold For: Feb 22

Feb 22, 2024 07:36 AM Harmony Biosciences (HRMY) Tops Q4 EPS by 1c

Feb 22, 2024 07:30 AM Harmony Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates

Feb 21, 2024 08:06 AM Harmony Biosciences (HRMY) Announces FDA Grants Priority Review for Application For Wakix (Pitolisant) In Pediatric Narcolepsy

Feb 21, 2024 08:05 AM U.S. FOOD AND DRUG ADMINISTRATION GRANTS PRIORITY REVIEW TO HARMONY BIOSCIENCES' APPLICATION FOR WAKIX® (PITOLISANT) IN PEDIATRIC NARCOLEPSY

Feb 20, 2024 08:05 AM Harmony Biosciences (HRMY) Receives U.S. Food And Drug Administration Orphan Drug Designation For Pitolisant In Prader-willi Syndrome

Feb 20, 2024 08:05 AM HARMONY BIOSCIENCES RECEIVES U.S. FOOD AND DRUG ADMINISTRATION ORPHAN DRUG DESIGNATION FOR PITOLISANT IN PRADER-WILLI SYNDROME

Feb 15, 2024 06:26 AM Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $42 at Mizuho Securities

Feb 13, 2024 07:07 PM Form SC 13G/A Harmony Biosciences Hold Filed by: Valor IV Pharma Holdings, LLC

Feb 13, 2024 05:11 PM Form SC 13G/A Harmony Biosciences Hold Filed by: VANGUARD GROUP INC

Feb 9, 2024 09:04 AM Form SC 13G/A Harmony Biosciences Hold Filed by: FMR LLC

Feb 8, 2024 08:05 AM HARMONY BIOSCIENCES TO REPORT FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS ON FEBRUARY 22, 2024

Jan 26, 2024 05:00 PM Form 4 Harmony Biosciences Hold For: Jan 24 Filed by: Budur Kumar

Jan 26, 2024 04:59 PM Form 3 Harmony Biosciences Hold For: May 01 Filed by: Budur Kumar

Jan 26, 2024 04:56 PM Form 4 Harmony Biosciences Hold For: Jan 24 Filed by: Dierks Jeffrey

Jan 26, 2024 04:56 PM Form 4 Harmony Biosciences Hold For: Jan 24 Filed by: Dayno Jeffrey M.

Jan 26, 2024 04:54 PM Form 4 Harmony Biosciences Hold For: Jan 24 Filed by: Serafin Andrew

Jan 26, 2024 04:53 PM Form 4 Harmony Biosciences Hold For: Jan 24 Filed by: Kapadia Sandip

Jan 24, 2024 02:28 PM Form SC 13G/A Harmony Biosciences Hold Filed by: BlackRock Inc.

Jan 9, 2024 05:59 AM Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $28 at Goldman Sachs

Jan 8, 2024 08:30 AM Form 8-K Harmony Biosciences Hold For: Jan 08

Jan 8, 2024 08:17 AM Harmony Biosciences (HRMY) Preliminary Unaudited Fourth Quarter And Full Year 2023 Net Product Revenue Increases

Jan 8, 2024 08:05 AM HARMONY BIOSCIENCES PRELIMINARY UNAUDITED FOURTH QUARTER AND FULL YEAR 2023 NET PRODUCT REVENUE INCREASES MORE THAN 30 PERCENT; PROVIDES 2024 NET PRODUCT REVENUE GUIDANCE

Jan 3, 2024 08:05 AM HARMONY BIOSCIENCES TO PRESENT AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

Jan 2, 2024 05:24 AM BofA Securities Downgrades Harmony Biosciences Holdings Inc. (HRMY) to Underperform, 'lack of catalysts + limited valuation upside'

Dec 7, 2023 04:07 PM Form 8-K/A Harmony Biosciences Hold For: Oct 10

Dec 7, 2023 08:06 AM Harmony Biosciences (HRMY) Announces Positive Topline Data From Phase 2 Signal Detection Study Evaluating Pitolisant In Adult Patients With Myotonic Dystrophy Type 1

Dec 7, 2023 08:05 AM HARMONY BIOSCIENCES ANNOUNCES POSITIVE TOPLINE DATA FROM PHASE 2 SIGNAL DETECTION STUDY EVALUATING PITOLISANT IN ADULT PATIENTS WITH MYOTONIC DYSTROPHY TYPE 1